Denosumab for Prevention of Skeletal-Related Events in Patients With Bone Metastases From Solid Tumors: Incremental Benefit, Debatable Value The original article 2 presented two estimates for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results